Episode
Best of UEG Week - HPB with Carolin Schneider
- Podcast
- UEG Podcast
- Published
- Nov 11, 2025
- Duration seconds
- 847
- Processing state
not_requested- Canonical source
- https://ueg-talks-podcast.podigee.io/62-new-episode
Actions
POST https://stenobird.com/v1/public/podcasts/ueg-podcast-6404464/episodes/best-of-ueg-week-hpb-with-carolin-schneider/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/ueg-podcast-6404464/best-of-ueg-week-hpb-with-carolin-schneider.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode, UEG's new Scientific Committee chair Jörn Schattenberg and Carolin Schneider, UEG rising start of 2025, recap the standout science from UEG Week 2025 in Berlin. They discuss highlights from the HPB field, including pivotal phase III data on linerixibat for cholestatic pruritus in PBC, advances in MASLD/MASH therapies such as FGF21 analogues and resmetirom, and new insights into liquid biopsy and AI-assisted imaging for pancreatic lesions. The conversation also explores simvastatin’s potential in preventing recurrent pancreatitis and reflects on the value of collaboration, precision medicine, and prospective clinical trials showcased at UEG Week.